Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Daxor Announces Review Published In Cardiorenal Medicine Highlighting The Role Of Blood Volume Analysis In Enhancing Care And Outcomes For Cardiorenal Syndrome; BVA Improves Precision In Diuretic And Red Cell Therapies For Personalized Treatment

Author: Benzinga Newsdesk | September 12, 2024 08:02am

Posted In: DXR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist